- Home
- INMB vs JHI Comparison
INMB vs JHI Comparison
Compare INMB & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- JHI
- Stock Information
- Founded
- INMB 2015
- JHI 1971
- Country
- INMB United States
- JHI United States
- Employees
- INMB N/A
- JHI N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- JHI Trusts Except Educational Religious and Charitable
- Sector
- INMB Health Care
- JHI Finance
- Exchange
- INMB Nasdaq
- JHI Nasdaq
- Market Cap
- INMB 123.0M
- JHI 121.0M
- IPO Year
- INMB 2019
- JHI N/A
- Fundamental
- Price
- INMB $5.10
- JHI $14.28
- Analyst Decision
- INMB Buy
- JHI
- Analyst Count
- INMB 1
- JHI 0
- Target Price
- INMB $22.00
- JHI N/A
- AVG Volume (30 Days)
- INMB 365.1K
- JHI 29.5K
- Earning Date
- INMB 10-30-2024
- JHI 01-01-0001
- Dividend Yield
- INMB N/A
- JHI 6.80%
- EPS Growth
- INMB N/A
- JHI N/A
- EPS
- INMB N/A
- JHI 1.05
- Revenue
- INMB $85,000.00
- JHI N/A
- Revenue This Year
- INMB N/A
- JHI N/A
- Revenue Next Year
- INMB N/A
- JHI N/A
- P/E Ratio
- INMB N/A
- JHI $12.47
- Revenue Growth
- INMB N/A
- JHI N/A
- 52 Week Low
- INMB $4.81
- JHI $11.63
- 52 Week High
- INMB $14.74
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- INMB 39.24
- JHI 65.79
- Support Level
- INMB $4.87
- JHI $13.73
- Resistance Level
- INMB $5.73
- JHI $14.48
- Average True Range (ATR)
- INMB 0.28
- JHI 0.12
- MACD
- INMB 0.05
- JHI 0.02
- Stochastic Oscillator
- INMB 28.88
- JHI 62.51
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.